CRA is a proud exhibiting sponsor of this event.
Cecile Matthews is presenting during the session titled “What is the relationship between price and prevalence in non-oncology rare disease?”
Greg Bell is presenting during the session titled “Simplifying patient tracking,” showcasing RD Navigator.
For more information on this event, click here.
Strategic implications for the 340B Rebate Model Pilot Program
These entities receive discounts on all eligible covered outpatient drugs. The program has expanded substantially over the years, with the number of covered...